Differential isoform profiles of α2-macroglobulin from plasma of patients with chronic-progressive or relapsing-remitting multiple sclerosis

Stephen Back, Jack A. Alhadeff

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Multiple sclerosis (MS) is a human neurological disease for which no clinically useful marker has been identified in blood. This study examined α2-macroglobulin (α2M) from the plasma of six patients with chronic-progressive MS and six with relapsing-remitting disease. The α2M trypsin-binding activity in the plasma from both groups of patients did not differ from normal controls. However, after column isoelectric focusing, consistently less α2M activity was recovered from the MS samples: those from the chronic-progressive and relapsing-remitting disease groups were an average of 43% and 68%, respectively, of controls. The number and isoelectric point (pI) values of the isoforms of the α2M from patients with chronicprogressive disease were similar to controls. The average pI of the major form for both groups was 6.6. By contrast, the average pI of the major form from the patients with relapsing-remitting MS was significantly elevated to 7.1, and this group displayed a significantly higher percentage of total recovered activity above pH 7.0. In eleven of the twelve cases examined, the pI of the major form of α2M correctly correlated with the clinical status of the patient. The original clinical diagnosis of the patients was reassessed by a 9-year retrospective interview which verified that 9 of the 10 patients in the follow-up group retained their original clinical diagnosis. These studies demonstrate differential isoform profiles of native α2M from MS patients with progressive versus remitting disease which may be useful in subclassifying MS patients.

Original languageEnglish (US)
Pages (from-to)27-36
Number of pages10
JournalClinica Chimica Acta
Volume211
Issue number1-2
DOIs
StatePublished - Oct 15 1992
Externally publishedYes

Fingerprint

Relapsing-Remitting Multiple Sclerosis
Macroglobulins
Protein Isoforms
Plasmas
Multiple Sclerosis
Trypsin
Chronic Progressive Multiple Sclerosis
Blood
Isoelectric Point
Isoelectric Focusing
Interviews

Keywords

  • Isoelectric focusing
  • Multiple sclerosis
  • α-Macroglobulin

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry

Cite this

Differential isoform profiles of α2-macroglobulin from plasma of patients with chronic-progressive or relapsing-remitting multiple sclerosis. / Back, Stephen; Alhadeff, Jack A.

In: Clinica Chimica Acta, Vol. 211, No. 1-2, 15.10.1992, p. 27-36.

Research output: Contribution to journalArticle

@article{8bf6d635ce9e4261931b3647115ae1b6,
title = "Differential isoform profiles of α2-macroglobulin from plasma of patients with chronic-progressive or relapsing-remitting multiple sclerosis",
abstract = "Multiple sclerosis (MS) is a human neurological disease for which no clinically useful marker has been identified in blood. This study examined α2-macroglobulin (α2M) from the plasma of six patients with chronic-progressive MS and six with relapsing-remitting disease. The α2M trypsin-binding activity in the plasma from both groups of patients did not differ from normal controls. However, after column isoelectric focusing, consistently less α2M activity was recovered from the MS samples: those from the chronic-progressive and relapsing-remitting disease groups were an average of 43{\%} and 68{\%}, respectively, of controls. The number and isoelectric point (pI) values of the isoforms of the α2M from patients with chronicprogressive disease were similar to controls. The average pI of the major form for both groups was 6.6. By contrast, the average pI of the major form from the patients with relapsing-remitting MS was significantly elevated to 7.1, and this group displayed a significantly higher percentage of total recovered activity above pH 7.0. In eleven of the twelve cases examined, the pI of the major form of α2M correctly correlated with the clinical status of the patient. The original clinical diagnosis of the patients was reassessed by a 9-year retrospective interview which verified that 9 of the 10 patients in the follow-up group retained their original clinical diagnosis. These studies demonstrate differential isoform profiles of native α2M from MS patients with progressive versus remitting disease which may be useful in subclassifying MS patients.",
keywords = "Isoelectric focusing, Multiple sclerosis, α-Macroglobulin",
author = "Stephen Back and Alhadeff, {Jack A.}",
year = "1992",
month = "10",
day = "15",
doi = "10.1016/0009-8981(92)90102-V",
language = "English (US)",
volume = "211",
pages = "27--36",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Differential isoform profiles of α2-macroglobulin from plasma of patients with chronic-progressive or relapsing-remitting multiple sclerosis

AU - Back, Stephen

AU - Alhadeff, Jack A.

PY - 1992/10/15

Y1 - 1992/10/15

N2 - Multiple sclerosis (MS) is a human neurological disease for which no clinically useful marker has been identified in blood. This study examined α2-macroglobulin (α2M) from the plasma of six patients with chronic-progressive MS and six with relapsing-remitting disease. The α2M trypsin-binding activity in the plasma from both groups of patients did not differ from normal controls. However, after column isoelectric focusing, consistently less α2M activity was recovered from the MS samples: those from the chronic-progressive and relapsing-remitting disease groups were an average of 43% and 68%, respectively, of controls. The number and isoelectric point (pI) values of the isoforms of the α2M from patients with chronicprogressive disease were similar to controls. The average pI of the major form for both groups was 6.6. By contrast, the average pI of the major form from the patients with relapsing-remitting MS was significantly elevated to 7.1, and this group displayed a significantly higher percentage of total recovered activity above pH 7.0. In eleven of the twelve cases examined, the pI of the major form of α2M correctly correlated with the clinical status of the patient. The original clinical diagnosis of the patients was reassessed by a 9-year retrospective interview which verified that 9 of the 10 patients in the follow-up group retained their original clinical diagnosis. These studies demonstrate differential isoform profiles of native α2M from MS patients with progressive versus remitting disease which may be useful in subclassifying MS patients.

AB - Multiple sclerosis (MS) is a human neurological disease for which no clinically useful marker has been identified in blood. This study examined α2-macroglobulin (α2M) from the plasma of six patients with chronic-progressive MS and six with relapsing-remitting disease. The α2M trypsin-binding activity in the plasma from both groups of patients did not differ from normal controls. However, after column isoelectric focusing, consistently less α2M activity was recovered from the MS samples: those from the chronic-progressive and relapsing-remitting disease groups were an average of 43% and 68%, respectively, of controls. The number and isoelectric point (pI) values of the isoforms of the α2M from patients with chronicprogressive disease were similar to controls. The average pI of the major form for both groups was 6.6. By contrast, the average pI of the major form from the patients with relapsing-remitting MS was significantly elevated to 7.1, and this group displayed a significantly higher percentage of total recovered activity above pH 7.0. In eleven of the twelve cases examined, the pI of the major form of α2M correctly correlated with the clinical status of the patient. The original clinical diagnosis of the patients was reassessed by a 9-year retrospective interview which verified that 9 of the 10 patients in the follow-up group retained their original clinical diagnosis. These studies demonstrate differential isoform profiles of native α2M from MS patients with progressive versus remitting disease which may be useful in subclassifying MS patients.

KW - Isoelectric focusing

KW - Multiple sclerosis

KW - α-Macroglobulin

UR - http://www.scopus.com/inward/record.url?scp=0026463023&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026463023&partnerID=8YFLogxK

U2 - 10.1016/0009-8981(92)90102-V

DO - 10.1016/0009-8981(92)90102-V

M3 - Article

VL - 211

SP - 27

EP - 36

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

IS - 1-2

ER -